In recent years in-vivo assessment of vertebral bone marrow (VBM) fat composition has been increasingly used in the investigation of osteoporosis and bone metabolism. Postmenopausal women represent a population of particular interest because they are at higher risk for osteoporosis resulting from estrogen deficiency which can be potentially aggravated by aromatase inhibitor (AI) therapy. The present study demonstrated a relative increase in vertebral bone marrow fat content quantified by chemical shift encoding-based water-fat MRI in patients receiving simultaneous AI and bisphosphonate (BP) therapy, contradicting previous findings reported in the literature.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords